In this study, the clinical relevance between the expression of both PLK1 and β-catenin and survival rates of patients with NSCLC revealed that high CTNNB1/PLK1 expression is inversely correlated with the survival rates, especially in metastatic NSCLC (Figure 1). This evidence concerns the gene PLK1 and non-small cell lung carcinoma.